DOCS — Dr Martens Cashflow Statement
0.000.00%
Last trade - 00:00- £718.59m
- £1.08bn
- £877.10m
- 92
- 75
- 16
- 67
Annual cashflow statement for Dr Martens, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 74.8 | 35.7 | 181 | 129 | 69.2 |
| Depreciation | |||||
| Non-Cash Items | 42.4 | 49.3 | 17 | 28 | 37.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -25.3 | 40.2 | -50.7 | -138 | -11.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 121 | 160 | 184 | 77.3 | 168 |
| Capital Expenditures | -21.9 | -18.6 | -25 | -51.4 | -28.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | 0.8 | 2.9 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -21.9 | -18.6 | -25 | -50.6 | -25.5 |
| Financing Cash Flow Items | -5.4 | -12.8 | -10.8 | -12 | -34 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -44 | -133 | -47 | -99.5 | -186 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 58.8 | -3.6 | 114 | -70.5 | -46.4 |